Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.36
- Piotroski Score 4.00
- Grade Underweight
- Symbol (OMI)
- Company Owens & Minor, Inc.
- Price $14.68
- Changes Percentage (0.69%)
- Change $0.1
- Day Low $14.54
- Day High $14.95
- Year High $28.35
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
- Last Earnings 10/29/2021
- Ex-Dividend for 5/16 Dividend 12/14/2021
- Dividend Payable 12/31/2021
- Today N/A
- Next Earnings (Estimated) 10/31/2024
- Fiscal Year End N/A
- Average Stock Price Target $28.00
- High Stock Price Target $54.00
- Low Stock Price Target $17.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.51
- Trailing P/E Ratio -34.04
- Forward P/E Ratio -34.04
- P/E Growth -34.04
- Net Income $-41,301,000
Income Statement
Quarterly
Annual
Latest News of OMI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Three Unusually Effective Strategies For Overcoming Self-Doubt
Self-doubt can hinder progress and lead to bigger issues. However, harnessing recklessness, seeking freedom from social pressures, and embracing experimentation can turn self-doubt into an opportunity...
By Forbes | 16 hours ago -
Myriad and Ultima to study UG 100 sequencing platform for genomics clinical tests
Myriad Genetics partners with Ultima Genomics to explore UG 100 sequencing platform for clinical tests in oncology and reproductive genomics. The collaboration aims to improve test performance and red...
By Yahoo! Finance | 16 hours ago -
Middle-class wages aren't keeping up. Some economists say policy is suppressing pay growth
Productivity in the U.S. increased significantly from 1979 to 2024, but hourly pay did not keep pace, leading to wage stagnation. Some economists suggest deliberate policy decisions have hindered work...
By CNBC | 17 hours ago
